Curis Inc (CRIS)

Mar 24, 2026

Curis, Inc. 2025 Annual Report: Emavusertib Development, Regulatory Pathways, and Key Business Risks - Minichart

Mar 24, 2026

Mar 24, 2026

Curis (NASDAQ: CRIS) warns on going concern amid emavusertib push - Stock Titan

Mar 24, 2026

Mar 23, 2026

CURIS (CRIS) CDO Jonathan Zung converts Series B preferred into 66,667 common shares - Stock Titan

Mar 23, 2026

Mar 23, 2026

Curis (CRIS) CMO converts Series B preferred stock to common shares - Stock Titan

Mar 23, 2026

Mar 23, 2026

CURIS INC (CRIS) CFO converts Series B preferred into 66,666 common shares - Stock Titan

Mar 23, 2026

Mar 23, 2026

Curis (CRIS) CEO converts Series B preferred stock into common shares - Stock Titan

Mar 23, 2026

Mar 23, 2026

Curis Inc (CRIS) director converts Series B preferred into 26,667 common shares - Stock Titan

Mar 23, 2026

Mar 23, 2026

[EFFECT] CURIS INC SEC Filing - Stock Titan

Mar 23, 2026

Mar 20, 2026

Curis Earnings Call: Clinical Momentum Amid Revenue Void - TipRanks

Mar 20, 2026

Mar 20, 2026

Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M - AlphaStreet

Mar 20, 2026

Mar 20, 2026

Curis (CRIS) Q4 2025 Earnings Call Transcript - AOL.com

Mar 20, 2026

Mar 20, 2026

Curis Inc stock faces renewed scrutiny amid pipeline delays and cash burn concerns - AD HOC NEWS

Mar 20, 2026

Mar 20, 2026

Curis, Inc. (NASDAQ:CRIS) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 20, 2026

Mar 20, 2026

CRIS: HC Wainwright & Co. Reiterates Buy Rating with $17.00 Pric - GuruFocus

Mar 20, 2026

Mar 20, 2026

CRIS Stock Price, Quote & Chart | CURIS INC (NASDAQ:CRIS) - ChartMill

Mar 20, 2026

Mar 20, 2026

Curis reports Q4 results, secures up to $80.8M financing By Investing.com - Investing.com India

Mar 20, 2026

Mar 20, 2026

Curis Inc (CRIS) Q4 2025 Earnings Call Highlights: A Turnaround with Strong Quarterly Profit ... By GuruFocus - Investing.com Canada

Mar 20, 2026

Mar 19, 2026

Curis Inc (CRIS) Q4 2025 Earnings Call Highlights: A Turnaround with Strong Quarterly Profit and Strategic Focus - GuruFocus

Mar 19, 2026

Mar 19, 2026

Curis Q4 2025 Earnings Call Transcript - MarketBeat

Mar 19, 2026

Mar 19, 2026

Curis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 19, 2026

Mar 19, 2026

Curis targets full enrollment in PCNSL registrational study within 12–18 months while advancing CLL proof-of-concept - MSN

Mar 19, 2026

Mar 19, 2026

Earnings call transcript: Curis Inc. Q4 2025 sees turnaround with net income - Investing.com India

Mar 19, 2026

Mar 19, 2026

Curis Inc’s NHL Prioritization, PCNSL Timeline Shifts, and CLL Data Delays Clash in 2025 Q4 Earnings Call - Bitget

Mar 19, 2026

Mar 19, 2026

Curis Reports Progress on Lymphoma Study & Expands CLL Research with EmavusertibNews and Statistics - IndexBox

Mar 19, 2026

Mar 19, 2026

Curis (CRIS) Q4 2025 Financial Results Conference Call Transcript - Bitget

Mar 19, 2026

Mar 19, 2026

Earnings call transcript: Curis Inc. Q4 2025 sees turnaround with net income By Investing.com - Investing.com South Africa

Mar 19, 2026

Mar 19, 2026

Curis: Fourth Quarter Earnings Overview - Bitget

Mar 19, 2026

Mar 19, 2026

Curis Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2026

Mar 19, 2026

Curis (CRIS) Q4 2025 Earnings Call Transcript - The Motley Fool

Mar 19, 2026

Mar 19, 2026

Curis Provides Fourth Quarter 2025 Business Update - Bitget

Mar 19, 2026

Mar 19, 2026

Curis (CRIS) Reports Lower Than Expected Q4 Revenue - GuruFocus

Mar 19, 2026

Mar 19, 2026

Curis Q4 & Full-Year 2025 Financial Results: $19.4M Net Income, $1.1M RevenueNews and Statistics - IndexBox

Mar 19, 2026

Mar 19, 2026

Curis: Overview of Fourth Quarter Financial Results - Bitget

Mar 19, 2026

Mar 19, 2026

Curis reports Q4 results, secures up to $80.8M financing - Investing.com

Mar 19, 2026

Mar 19, 2026

Curis Inc Q4 revenue misses estimates - TradingView

Mar 19, 2026

Mar 19, 2026

Curis: Q4 Earnings Snapshot - marketscreener.com

Mar 19, 2026

Mar 19, 2026

Curis (CRIS) swings to Q4 profit but warns of funding shortfall - Stock Titan

Mar 19, 2026

Mar 19, 2026

Curis’s Emavusertib Trial Pause: What AML and MDS Investors Need to Know - TipRanks

Mar 19, 2026

Mar 18, 2026

Curis Shareholders Approve Major Equity and Charter Changes - The Globe and Mail

Mar 18, 2026

Mar 18, 2026

Curis (NASDAQ: CRIS) CDO acquires Series B preferred and warrants - Stock Titan

Mar 18, 2026

Mar 18, 2026

Curis (CRIS) CMO acquires Series B preferred stock and warrant package - Stock Titan

Mar 18, 2026

Mar 18, 2026

Curis (CRIS) CFO granted preferred stock and multi-series warrant package - Stock Titan

Mar 18, 2026

Mar 18, 2026

Curis (CRIS) CEO receives Series B preferred stock and large warrant grants - Stock Titan

Mar 18, 2026

Mar 18, 2026

Curis (CRIS) director receives Series B preferred and multi-series warrant grants - Stock Titan

Mar 18, 2026

Mar 18, 2026

Curis, Inc. 8-K SEC Filing Details: Company Information, Address, and Regulatory Compliance (March 17, 2026) - Minichart

Mar 18, 2026

Mar 17, 2026

Curis (NASDAQ: CRIS) ups share authorization and clears expansive 2026 incentive plan - Stock Titan

Mar 17, 2026

Mar 13, 2026

Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026 - BioSpace

Mar 13, 2026

Mar 12, 2026

Curis to Report Fourth Quarter 2025 Financial and Operating Resu - GuruFocus

Mar 12, 2026